Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of medicare beneficiaries

Cancer

Volumn 106, Issue 4, 2006, Pages 923-930

  Polite, Blase M ^a,d   Lamont, Elizabeth B ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Breast neoplasms; Colorectal neoplasms; Pulmonary embolism; Venous thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MASS SCREENING; MEDICARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 32544432101     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21672     Document Type: Article

References (35)

1. Gale JA, Gordon SG. Update on tumor cell procoagulant factors. Acta Haematol. 2001;106:25-32.
2. Monreal M, Casals A, Boix J, Olazabal A, Montserrat E, Mundo MR. Occult cancer in patients with acute pulmonary embolism. Chest. 1993;103:816-819.
3. Baron JA, Gridley G, Weiderpass E, Olof N, Linet M. Venous thromboembolism and cancer. Lancet. 1998;351:1077-1080.
4. Prandoni P, Lensing A, Buller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 1992;327:1128-33.
5. Bastounis EA, Karayiannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med. 1996;239:153-156.
6. Monreal M, Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E. Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost. 1997;78:1316-1318.
7. Hettiarachchi R, Lok J, Prins MH, Buller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis. Cancer. 1998;83:180-185.
8. Sorensen HT, Mellemjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med. 1998;338:1169-1173.
9. Rajan R, Levine M, Gent M, Geerts W, Skingley P, Julian J. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study. Thromb Haemost. 1998;79:19-22.
10. Griffin MR, Stanson AW, Brown ML, et al. Deep venous thrombosis and pulmonary embolism. Arch Intern Med. 1987;147:1907-1911.
11. Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstron T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ. 1994;308:891-894.
12. Cornuz J, Pearson S, Creager M, Francis EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med. 1996;125:785-793.
13. Ries LAG, Kosary CL, Hankey BF, et al. SEER cancer statistics review, 1973-1994. NIH Pub. No. 97-2789. Bethesda, MD: National Cancer Institute, 1997.
14. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50:939-945.
15. Hatten J. Medicare's common denominator: the covered population. Health Care Financ Rev. 1980;2:53-64.
16. Morgan RO, Virnig BA, DeVito CE, Persily NA. The Medicare-HMO revolving door-the healthy go in and the sick go out. N Engl J Med. 1997;337:169-175.
17. Levitan N, Dowlati A, Remic SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine. 1999;78:285-291.
18. Kniffin WD, Baron J, Barret J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep vein thrombosis in the elderly. Arch Intern Med. 1994;154:860-866.
19. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a Census-based methodology. Am J Public Health. 1992;92:703-710.
20. Hofer TP, Wolfe RA, Tedeshci PJ, McMahon LF, Griffith JR. Use of community versus individual socioeconomic data in predicting variation in hospital use. Health Serv Res. 1998;33:243-259.
21. Metersky M, Tate I, Fine MJ, Petrillo MK, Meehan TP. Temporal trends in outcomes of older patients with pneumonia. Arch Intern Med. 2000;160:3385-3391.
22. Yuan, Z, Bowlin S, Einstadter D, Cebul RD, Conners AR Jr., Rimm AA. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health. 1998;88:395-400.
23. Houch PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004;164:637-644.
24. Piccioli A, Lensing AWA, Prins MH, et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost. 2004;2:884-889.
25. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States. Cancer. 2003;97:1528-1540.
26. Vijan S, Inadomi J, Hawyard RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther. 2004;20:507-515.
27. Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997;47:150-153.
28. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-560.
29. Lauderdale DS, Goldberg J. The expanded racial and ethnic codes in the Medicare data files: their completeness of coverage and accuracy. Am J Public Health. 1996;86:712-716.
30. Mitchell JB, Bubolz T, Paul JE, et al. Using Medicare claims for outcomes research. Med Care. 1994;32:JS38-JS51.
31. Fisher ES, Baron JA, Malenka DJ, Barrett J, Bubolz TA. Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health. 1990;80:1487-1490.
32. Lauderdale D, Furner SE, Miles TP, Goldberg J. Epidemiological uses of Medicare data. Epidemiol Rev. 1993;15:319-327.
33. Geronimus AT, Bound I, Neidert LI. On the validity of using Census geocode characteristics to proxy individual socioeconomic characteristics. J Am Stat Assoc. 1996;91:529-537.
34. Robinson WS. Ecological correlations and the behavior of individuals. Am Sociol Rev. 1950;15:351-357.
35. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99-106.